The growing incidence and severity of Clostridium difficile infection in inpatient and outpatient settings

Expert Review of Gastroenterology and Hepatology

Volumn 4, Issue 4, 2010, Pages 409-416

  Khanna, Sahil ^a   Pardi, Darrell S ^a  

^a Mayo Clinic   (United States)

Author keywords

Clostridium difficile infection; colitis; community acquired; nosocomial

Indexed keywords

ANTIBIOTIC AGENT; CLINDAMYCIN; PENICILLIN G; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNICABLE DISEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG USE; FOOD POISONING; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INCIDENCE; INFECTION RATE; INFECTION RISK; MORBIDITY; MORTALITY; NONHUMAN; OUTPATIENT; REVIEW;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DIARRHEA; DRUG RESISTANCE, BACTERIAL; ENTEROCOLITIS, PSEUDOMEMBRANOUS; HUMANS; INCIDENCE; INPATIENTS; OUTPATIENTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VIRULENCE;

EID: 77955260309     PISSN: 17474124     EISSN: None     Source Type: Journal    
DOI: 10.1586/egh.10.48     Document Type: Review

References (116)

1. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N. Engl. J. Med. 298(10), 531-534 (1978). (Pubitemid 8295586)
2. Campbell RJ, Giljahn L, Machesky K et al. Clostridium diffcile infection in Ohio hospitals and nursing homes during 2006. Infect. Control Hosp. Epidemiol. 30(6), 526-533 (2009).
3. Dallal RM, Harbrecht BG, Boujoukas AJ et al. Fulminant Clostridium diffcile: an underappreciated and increasing cause of death and complications. Ann. Surg. 235(3), 363-372 (2002).
4. Loo VG, Poirier L, Miller MA et al. A predominantly clonal multi-institutional outbreak of Clostridium diffcile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 353(23), 2442-2449 (2005).
5. McDonald LC, Owings M, Jernigan DB. Clostridium diffcile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg. Infect. Dis. 12(3), 409-415 (2006).
6. Muto CA, Pokrywka M, Shutt K et al. A large outbreak of Clostridium diffcile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fuoroquinolone use. Infect. Control Hosp. Epidemiol. 26(3), 273-280 (2005).
7. Pepin J, Valiquette L, Cossette B. Mortality attributable to nosocomial Clostridium diffcile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. CMAJ 173(9), 1037-1042 (2005).
8. Zilberberg MD. Clostridium diffcile-related hospitalizations among US adults, 2006. Emerg. Infect. Dis. 15(1), 122-124 (2009).
9. Zilberberg MD, Shorr AF, Kollef MH. Increase in Clostridium diffcile-related hospitalizations among infants in the United States, 2000-2005. Pediatr. Infect. Dis. J. 27(12), 1111-1113 (2008).
10. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium diffcile colitis in hospitalized patients in the United States. Arch. Surg. 142(7), 624-631; discussion 631 (2007).
11. Zilberberg MD, Shorr AF, Kollef MH. Increase in adult Clostridium diffcile-related hospitalizations and case-fatality rate, United States, 2000-2005. Emerg. Infect. Dis. 14(6), 929-931 (2008).
12. Pepin J, Alary ME, Valiquette L et al. Increasing risk of relapse after treatment of Clostridium diffcile colitis in Quebec, Canada. Clin. Infect. Dis. 40(11), 1591-1597 (2005).
13. Pepin J, Valiquette L, Alary ME et al. Clostridium diffcile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. CMAJ 171(5), 466-472 (2004).
14. Gould M. Number of C. diffcile cases rises. BMJ 333(7561), 215 (2006).
15. Asensio A, Vaque-Rafart J, Calbo-Torrecillas F et al. Increasing rates in Clostridium diffcile infection (CDI) among hospitalised patients, Spain 1999-2007. Euro Surveill. 13(31) 18943 (2008).
16. Bacci S, St-Martin G, Olesen B et al. Outbreak of Clostridium diffcile 027 in North Zealand, Denmark, 2008-2009. Euro Surveill. 14(16) 19183 (2009).
17. Borgmann S, Kist M, Jakobiak T et al. Increased number of Clostridium diffcile infections and prevalence of Clostridium diffcile PCR ribotype 001 in southern Germany. Euro Surveill. 13(49) 19057 (2008).
18. Burckhardt F, Friedrich A, Beier D, Eckmanns T. Clostridium diffcile surveillance trends, Saxony, Germany. Emerg. Infect. Dis. 14(4), 691-692 (2008).
19. Graf K, Cohrs A, Gastmeier P et al. An outbreak of Clostridium diffcile-associated disease (CDAD) in a German university hospital. Eur. J. Clin. Microbiol. Infect. Dis. 28(5), 543-545 (2009).
20. Joseph R, Demeyer D, Vanrenterghem D, van den Berg R, Kuijper E, Delmee M. First isolation of Clostridium diffcile PCR ribotype 027, toxinotype III in Belgium. Euro Surveill. 10(10), E051020.4 (2005).
21. Lambert ML, Mertens K, Ramboer I, Delmee M, Suetens C. Nation-wide prospective surveillance of Clostridium diffcile infections in hospitals in Belgium, July 2007-June 2008. Euro Surveill. 14(14), 2-4 (2009).
22. Lyytikainen O, Turunen H, Sund R et al. Hospitalizations and deaths associated with Clostridium diffcile infection, Finland, 1996-2004. Emerg. Infect. Dis. 15(5), 761-765 (2009).
23. Soler P, Nogareda F, Cano R. Rates of Clostridium diffcile infection in patients discharged from Spanish hospitals, 1997-2005. Infect. Control Hosp. Epidemiol. 29(9), 887-889 (2008).
24. Van den Hof S, van der Kooi T, van den Berg R, Kuijper EJ, Notermans DW. Clostridium diffcile PCR ribotype 027 outbreaks in The Netherlands: recent surveillance data indicate that outbreaks are not easily controlled but interhospital transmission is limited. Euro Surveill. 11(1), E060126.2 (2006).
25. Gravel D, Miller M, Simor A et al. Health care-associated Clostridium diffcile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clin. Infect. Dis. 48(5), 568-576 (2009).
26. Archibald LK, Banerjee SN, Jarvis WR. Secular trends in hospital-acquired Clostridium diffcile disease in the United States, 1987-2001. J. Infect. Dis. 189(9), 1585-1589 (2004).
27. Salazar M, Baskin L, Garey K W, DuPont HL. Clostridium diffcile-related death rates in Texas 1999-2005. J. Infect. 59(5), 303-307 (2009).
28. Kelly CP, LaMont JT. Clostridium diffcile-more diffcult than ever. N. Engl. J. Med. 359(18), 1932-1940 (2008).
29. Morris AM, Jobe BA, Stoney M, Sheppard BC, Deveney CW, Deveney KE. Clostridium diffcile colitis: an increasingly aggressive iatrogenic disease? Arch. Surg. 137(10), 1096-1100 (2002).
30. Kelly CP, LaMont JT. Clostridium diffcile infection. Annu. Rev. Med. 49, 375-390 (1998).
31. Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC. Clostridium diffcile colitis: an increasing hospital-acquired illness. Am. J. Surg. 169(5), 480-483 (1995).
32. Karlstrom O, Fryklund B, Tullus K, Burman LG. A prospective nationwide study of Clostridium diffcile-associated diarrhea in Sweden. The Swedish C. diffcile Study Group. Clin. Infect. Dis. 26(1), 141-145 (1998).
33. Goorhuis A, Van der Kooi T, Vaessen N et al. Spread and epidemiology of Clostridium diffcile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands. Clin. Infect. Dis. 45(6), 695-703 (2007).
34. McDonald LC, Killgore GE, Thompson A et al. An epidemic, toxin gene-variant strain of Clostridium diffcile. N. Engl. J. Med. 353(23), 2433-2441 (2005).
35. McFarland LV, Clarridge JE, Beneda H W, Raugi GJ. Fluoroquinolone use and risk factors for Clostridium diffcile-associated disease within a Veterans Administration health care system. Clin. Infect. Dis. 45(9), 1141-1151 (2007).
36. Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A case-control study of community-associated Clostridium diffcile infection. J. Antimicrob. Chemother. 62(2), 388-396 (2008).
37. Frost F, Hurley JS, Petersen HV, Casciano RN. Estimated incidence of Clostridium diffcile infection. Emerg. Infect. Dis. 5(2), 303-304 (1999).
38. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium diffcile-associated disease. JAMA 294(23), 2989-2995 (2005).
39. Beaugerie L, Flahault A, Barbut F et al. Antibiotic-associated diarrhoea and Clostridium diffcile in the community. Aliment. Pharmacol. Ther. 17(7), 905-912 (2003).
40. Noren T, Akerlund T, Back E et al. Molecular epidemiology of hospital-associated and community-acquired Clostridium diffcile infection in a Swedish county. J. Clin. Microbiol. 42(8), 3635-3643 (2004).
41. Centers for Disease Control and Prevention. Severe Clostridium diffcile-associated disease in populations previously at low risk-four states, 2005. MMWR Morb. Mortal. Wkly Rep. 54(47), 1201-1205 (2005).
42. Khanna S, Aronson SL, Kammer PP, Orenstein R, Pardi DS. Comparison between community acquired and hospital acquired Clostridium diffcile infection: a population-based study. Am. J. Gastroenterol. 104(S3), S183 (2009).
43. Bauer MP, Goorhuis A, Koster T et al. Community-onset Clostridium diffcile-associated diarrhoea not associated with antibiotic usage-two case reports with review of the changing epidemiology of Clostridium diffcile-associated diarrhoea. Neth. J. Med. 66(5), 207-211 (2008).
44. Dial S, Kezouh A, Dascal A, Barkun A, Suissa S. Patterns of antibiotic use and risk of hospital admission because of Clostridium diffcile infection. CMAJ 179(8), 767-772 (2008).
45. Hubert B, Gilca R. Use administrative databases with caution. CMAJ 180(1), 78; author reply 78-79 (2009).
46. Hirschhorn LR, Trnka Y, Onderdonk A, Lee ML, Platt R. Epidemiology of community-acquired Clostridium diffcile-associated diarrhea. J. Infect. Dis. 169(1), 127-133 (1994).
47. Rupnik M. Is Clostridium diffcile-associated infection a potentially zoonotic and foodborne disease? Clin. Microbiol. Infect. 13(5), 457-459 (2007).
48. Jhung MA, Thompson AD, Killgore GE et al. Toxinotype V Clostridium diffcile in humans and food animals. Emerg. Infect. Dis. 14(7), 1039-1045 (2008).
49. Weese JS. Clostridium diffcile in food-innocent bystander or serious threat? Clin. Microbiol. Infect. 16(1), 3-10 (2010).
50. Indra A, Lassnig H, Baliko N et al. Clostridium diffcile: a new zoonotic agent? Wien. Klin. Wochenschr. 121(3-4), 91-95 (2009).
51. Weese JS, Avery BP, Rousseau J, Reid-Smith RJ. Detection and enumeration of Clostridium diffcile spores in retail beef and pork. Appl. Environ. Microbiol. 75(15), 5009-5011 (2009).
52. Keel MK, Songer JG. The distribution and density of Clostridium diffcile toxin receptors on the intestinal mucosa of neonatal pigs. Vet. Pathol. 44(6), 814-822 (2007).
53. Keel K, Brazier JS, Post K W, Weese S, Songer JG. Prevalence of PCR ribotypes among Clostridium diffcile isolates from pigs, calves, and other species. J. Clin. Microbiol. 45(6), 1963-1964 (2007).
54. Avbersek J, Janezic S, Pate M et al. Diversity of Clostridium diffcile in pigs and other animals in Slovenia. Anaerobe 15(6), 252-255 (2009).
55. Pirs T, Ocepek M, Rupnik M. Isolation of Clostridium diffcile from food animals in Slovenia. J. Med. Microbiol. 57(Pt 6), 790-792 (2008).
56. Rodriguez-Palacios A, Stampfi HR, Duffeld T et al. Clostridium diffcile PCR ribotypes in calves, Canada. Emerg. Infect. Dis. 12(11), 1730-1736 (2006).
57. Jobstl M, Heuberger S, Indra A, Nepf R, Kofer J, Wagner M. Clostridium diffcile in raw products of animal origin. Int. J. Food Microbiol. 138(1-2), 172-175 (2010).
58. Weese JS, Reid-Smith RJ, Avery BP, Rousseau J. Detection and characterization of Clostridium diffcile in retail chicken. Lett. Appl. Microbiol. 50(4), 362-365 (2010).
59. Rodriguez-Palacios A, Reid-Smith RJ, Staempfi HR et al. Possible seasonality of Clostridium diffcile in retail meat, Canada. Emerg. Infect. Dis. 15(5), 802-805 (2009).
60. Rodriguez-Palacios A, Staempfi HR, Duffeld T, Weese JS. Clostridium diffcile in retail ground meat, Canada. Emerg. Infect. Dis. 13(3), 485-487 (2007).
61. Songer JG, Trinh HT, Killgore GE, Thompson AD, McDonald LC, Limbago BM. Clostridium diffcile in retail meat products, USA, 2007. Emerg. Infect. Dis. 15(5), 819-821 (2009).
62. Rodriguez-Palacios A, Reid-Smith RJ, Staempfi HR, Weese JS. Clostridium diffcile survives minimal temperature recommended for cooking ground meats. Anaerobe DOI:10.1016/j.anaerobe. 2010.05.004 (2010) (Epub ahead of print).
63. Freeman J, Wilcox MH. The effects of storage conditions on viability of Clostridium diffcile vegetative cells and spores and toxin activity in human faeces. J. Clin. Pathol. 56(2), 126-128 (2003).
64. Gastmeier P, Weitzel-Kage D, Behnke M, Eckmanns T. Surveillance of Clostridium diffcile-associated diarrhoea with the German nosocomial infection surveillance system KISS (CDAD-KISS). Int. J. Antimicrob. Agents 33(Suppl. 1), S19-S23 (2009).
65. Fraser TG, Fatica C, Gordon SM. Necessary but not suffcient: a comparison of surveillance defnitions of Clostridium diffcile-associated diarrhea. Infect. Control Hosp. Epidemiol. 30(4), 377-379 (2009).
66. Shears P, Prtak L, Duckworth R. Hospital-based epidemiology: a strategy for 'dealing with Clostridium diffcile'. J. Hosp. Infect. 74(4), 319-325 (2010).
67. McDonald LC, Coignard B, Dubberke E et al. Recommendations for surveillance of Clostridium diffcile-associated disease. Infect. Control Hosp. Epidemiol. 28(2), 140-145 (2007).
68. Lambert PJ, Dyck M, Thompson LH, Hammond GW. Population-based surveillance of Clostridium diffcile infection in Manitoba, Canada, by using interim surveillance defnitions. Infect. Control Hosp. Epidemiol. 30(10), 945-951 (2009).
69. Kutty PK, Benoit SR, Woods CW et al. Assessment of Clostridium diffcile-associated disease surveillance defnitions, North Carolina, 2005. Infect. Control Hosp. Epidemiol. 29(3), 197-202 (2008).
70. Dubberke ER, McMullen KM, Mayfeld JL et al. Hospital-associated Clostridium diffcile infection: is it necessary to track community-onset disease? Infect. Control Hosp. Epidemiol. 30(4), 332-337 (2009).
71. Dubberke ER, Butler AM, Hota B et al. Multicenter study of the impact of community-onset Clostridium diffcile infection on surveillance for C. diffcile infection. Infect. Control Hosp. Epidemiol. 30(6), 518-525 (2009).
72. Kim J, Smathers SA, Prasad P, Leckerman KH, Coffn S, Zaoutis T. Epidemiological features of Clostridium diffcile-associated disease among inpatients at children's hospitals in the United States, 2001-2006. Pediatrics 122(6), 1266-1270 (2008).
73. Klein EJ, Boster DR, Stapp JR et al. Diarrhea etiology in a Children's Hospital Emergency Department: a prospective cohort study. Clin. Infect. Dis. 43(7), 807-813 (2006).
74. Morinville V, McDonald J. Clostridium diffcile-associated diarrhea in 200 Canadian children. Can. J. Gastroenterol. 19(8), 497-501 (2005).
75. Rexach CE, Tang-Feldman YJ, Cohen SH. Spatial and temporal analysis of Clostridium diffcile infection in patients at a pediatric hospital in California. Infect. Control Hosp. Epidemiol. 26(8), 691-696 (2005).
76. Rouphael NG, O'Donnell JA, Bhatnagar J et al. Clostridium diffcile-associated diarrhea: an emerging threat to pregnant women. Am. J. Obstet. Gynecol. 198(6), 635e1-e6 (2008).
77. Rodemann JF, Dubberke ER, Reske KA, Seo da H, Stone CD. Incidence of Clostridium diffcile infection in infammatory bowel disease. Clin. Gastroenterol. Hepatol. 5(3), 339-344 (2007).
78. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium diffcile in patients with infammatory bowel disease. Gut 57(2), 205-210 (2008).
79. Nguyen GC, Kaplan GG, Harris ML, Brant SR. A national survey of the prevalence and impact of Clostridium diffcile infection among hospitalized infammatory bowel disease patients. Am. J. Gastroenterol. 103(6), 1443-1450 (2008).
80. Ricciardi R, Ogilvie JW Jr, Roberts PL, Marcello PW, Concannon TW, Baxter NN. Epidemiology of Clostridium diffcile colitis in hospitalized patients with infammatory bowel diseases. Dis. Colon Rectum 52(1), 40-45 (2009).
81. Clayton EM, Rea MC, Shanahan F et al. The vexed relationship between Clostridium diffcile and infammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am. J. Gastroenterol. 104(5), 1162-1169 (2009).
82. Lumpkins K, Bochicchio GV, Joshi M et al. Clostridium diffcile infection in critically injured trauma patients. Surg. Infect. (Larchmt) 9(5), 497-501 (2008).
83. Ang CW, Heyes G, Morrison P, Carr B. The acquisition and outcome of ICU-acquired Clostridium diffcile infection in a single centre in the UK. J. Infect. 57(6), 435-440 (2008).
84. Lawrence SJ, Puzniak LA, Shadel BN, Gillespie KN, Kollef MH, Mundy LM. Clostridium diffcile in the intensive care unit: epidemiology, costs, and colonization pressure. Infect. Control Hosp. Epidemiol. 28(2), 123-130 (2007).
85. Henrich TJ, Krakower D, Bitton A, Yokoe DS. Clinical risk factors for severe Clostridium diffcile-associated disease. Emerg. Infect. Dis. 15(3), 415-422 (2009).
86. Moshkowitz M, Ben-Baruch E, Kline Z, Shimoni Z, Niven M, Konikoff F. Risk factors for severity and relapse of pseudomembranous colitis in an elderly population. Colorectal Dis. 9(2), 173-177 (2007).
87. Lamontagne F, Labbe AC, Haeck O et al. Impact of emergency colectomy on survival of patients with fulminant Clostridium diffcile colitis during an epidemic caused by a hypervirulent strain. Ann. Surg. 245(2), 267-272 (2007).
88. Zar FA, Bakkanagari SR, Moorthi KM, Davis MB. A comparison of vancomycin and metronidazole for the treatment of Clostridium diffcile-associated diarrhea, stratifed by disease severity. Clin. Infect. Dis. 45(3), 302-307 (2007).
89. Byrn JC, Maun DC, Gingold DS, Baril DT, Ozao JJ, Divino CM. Predictors of mortality after colectomy for fulminant Clostridium diffcile colitis. Arch. Surg. 143(2), 150-154; discussion 155 (2008).
90. Hall JF, Berger D. Outcome of colectomy for Clostridium diffcile colitis: a plea for early surgical management. Am. J. Surg. 196(3), 384-388 (2008).
91. Redelings MD, Sorvillo F, Mascola L. Increase in Clostridium diffcile-related mortality rates, United States, 1999-2004. Emerg. Infect. Dis. 13(9), 1417-1419 (2007).
92. Song X, Bartlett JG, Speck K, Naegeli A, Carroll K, Perl TM. Rising economic impact of Clostridium diffcile-associated disease in adult hospitalized patient population. Infect. Control Hosp. Epidemiol. 29(9), 823-828 (2008).
93. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium diffcile. Clin. Infect. Dis. 34(3), 346-353 (2002).
94. Vonberg RP, Reichardt C, Behnke M, Schwab F, Zindler S, Gastmeier P. Costs of nosocomial Clostridium diffcile-associated diarrhoea. J. Hosp. Infect. 70(1), 15-20 (2008).
95. Wilcox MH, Cunniffe JG, Trundle C, Redpath C. Financial burden of hospital-acquired Clostridium diffcile infection. J. Hosp. Infect. 34(1), 23-30 (1996).
96. Miller M, Gravel D, Mulvey M et al. Health care-associated Clostridium diffcile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality. Clin. Infect. Dis. 50(2), 194-201 (2010).
97. Warny M, Pepin J, Fang A et al. Toxin production by an emerging strain of Clostridium diffcile associated with outbreaks of severe disease in North America and Europe. Lancet 366(9491), 1079-1084 (2005).
98. Pepin J, Saheb N, Coulombe MA et al. Emergence of fuoroquinolones as the predominant risk factor for Clostridium diffcile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin. Infect. Dis. 41(9), 1254-1260 (2005).
99. Kyne L, Sougioultzis S, McFarland LV, Kelly CP. Underlying disease severity as a major risk factor for nosocomial Clostridium diffcile diarrhea. Infect. Control Hosp. Epidemiol. 23(11), 653-659 (2002).
100. Price MF, Dao-Tran T, Garey KW et al. Epidemiology and incidence of Clostridium diffcile-associated diarrhoea diagnosed upon admission to a university hospital. J. Hosp. Infect. 65(1), 42-46 (2007).
101. Barbut F, Gariazzo B, Bonne L et al. Clinical features of Clostridium diffcile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. Infect. Control Hosp. Epidemiol. 28(2), 131-139 (2007).
102. Dubberke ER, Sadhu J, Gatti R et al. Severity of Clostridium diffcile-associated disease (CDAD) in allogeneic stem cell transplant recipients: evaluation of a CDAD severity grading system. Infect. Control Hosp. Epidemiol. 28(2), 208-211 (2007).
103. Labbe AC, Poirier L, Maccannell D et al. Clostridium diffcile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. Antimicrob. Agents Chemother. 52(9), 3180-3187 (2008).
104. Brazier JS, Raybould R, Patel B et al. Distribution and antimicrobial susceptibility patterns of Clostridium diffcile PCR ribotypes in English hospitals, 2007-2008. Euro Surveill. 13(41) 19000 (2008).
105. Cheng VC, Yam WC, Chan JF, To KK, Ho PL, Yuen KY. Clostridium diffcile ribotype 027 arrives in Hong Kong. Int. J. Antimicrob. Agents 34(5), 492-493 (2009).
106. Fenner L, Widmer AF, Stranden A et al. First cluster of clindamycin-resistant Clostridium diffcile PCR ribotype 027 in Switzerland. Clin. Microbiol. Infect. 14(5), 514-515 (2008).
107. Goorhuis A, Bakker D, Corver J et al. Emergence of Clostridium diffcile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis. 47(9), 1162-1170 (2008).
108. Indra A, Huhulescu S, Fiedler A, Kernbichler S, Blaschitz M, Allerberger F. Outbreak of Clostridium diffcile 027 infection in Vienna, Austria 2008-2009. Euro Surveill. 14(17) 19186 (2009).
109. Indra A, Huhulescu S, Hasenberger P et al. First isolation of Clostridium diffcile PCR ribotype 027 in Austria. Euro Surveill. 11(9), E060914.3 (2006).
110. Notermans DW, van der Kooi TI, Goorhuis A, Debast SB, van Benthem BH, Kuijper EJ. [Epidemiology of Clostridium diffcile PCR ribotype 027 in The Netherlands 2005-present and the emergence of other subtypes]. Ned. Tijdschr. Geneeskd. 152(35), 1937-1940 (2008).
111. Pituch H, Bakker D, Kuijper E et al. First isolation of Clostridium diffcile PCR-ribotype 027/toxinotype III in Poland. Pol. J. Microbiol. 57(3), 267-268 (2008).
112. Riley T V, Thean S, Hool G, Golledge CL. First Australian isolation of epidemic Clostridium diffcile PCR ribotype 027. Med. J. Aust. 190(12), 706-708 (2009).
113. Shin BM, Kuak EY, Yoo HM et al. Multicentre study of the prevalence of toxigenic Clostridium diffcile in Korea: results of a retrospective study 2000-2005. J. Med. Microbiol. 57(Pt 6), 697-701 (2008).
114. Cloud J, Noddin L, Pressman A, Hu M, Kelly C. Clostridium diffcile strain NAP-1 is not associated with severe disease in a nonepidemic setting. Clin. Gastroenterol. Hepatol. 7(8), 868-873, e862 (2009).
115. Morgan OW, Rodrigues B, Elston T et al. Clinical severity of Clostridium diffcile PCR ribotype 027: a case-case study. PLoS One 3(3), e1812 (2008).
116. Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RL, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium diffcile strains among long-term care facility residents. Clin. Infect. Dis. 45(8), 992-998 (2007).